Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT01850758
43:53:cancer,132:141:treatment,145:167:treatment
Tested positive or has been treated for a malignancy in the past or is suspected of having a malignancy or is currently undergoing radiation or chemotherapy treatment for a malignancy anywhere in the body, whether adjacent to or distant from the proposed injection site
1
[ "Tested", "positive", "or", "has", "been", "treated", "for", "a", "malignancy", "in", "the", "past", "or", "is", "suspected", "of", "having", "a", "malignancy", "or", "is", "currently", "undergoing", "radiation", "or", "chemotherapy", "treatment", "for", "a", "malignancy", "anywhere", "in", "the", "body", ",", "whether", "adjacent", "to", "or", "distant", "from", "the", "proposed", "injection", "site" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01187368
51:68:treatment
Patients with an unacceptable risk for successful LVAD implantation and maintenance
1
[ "Patients", "with", "an", "unacceptable", "risk", "for", "successful", "LVAD", "implantation", "and", "maintenance" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0 ]
NCT01367444
34:54:chronic_disease,56:66:chronic_disease,68:81:chronic_disease,86:106:treatment
History or signs consistent with unilateral amblyopia (strabismic, anisometropic, or stimulus deprivation)
1
[ "History", "or", "signs", "consistent", "with", "unilateral", "amblyopia", "(", "strabismic", ",", "anisometropic", ",", "or", "stimulus", "deprivation", ")" ]
[ 0, 0, 0, 0, 0, 2, 2, 0, 2, 0, 2, 0, 0, 1, 1, 0 ]
NCT00432094
1:11:chronic_disease
arrhythmia
1
[ "arrhythmia" ]
[ 2 ]
NCT03120585
1:27:chronic_disease,31:63:chronic_disease,67:83:chronic_disease
Neonates with hypoglycemia or clinical evidence of dehydration or volume depletion requiring fluid bolus
1
[ "Neonates", "with", "hypoglycemia", "or", "clinical", "evidence", "of", "dehydration", "or", "volume", "depletion", "requiring", "fluid", "bolus" ]
[ 2, 2, 2, 0, 2, 2, 2, 2, 0, 2, 2, 0, 0, 0 ]
NCT02321501
1:19:chronic_disease,58:73:cancer,127:145:cancer
Measurable disease by RECIST or evaluable disease (e.g., bone metastasis, or lesions which do not fulfill RECIST criteria for metastatic disease)
1
[ "Measurable", "disease", "by", "RECIST", "or", "evaluable", "disease", "(", "e.g.", ",", "bone", "metastasis", ",", "or", "lesions", "which", "do", "not", "fulfill", "RECIST", "criteria", "for", "metastatic", "disease", ")" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0 ]
NCT00107289
1:5:treatment,11:13:cancer,39:48:treatment
MIBG-avid NB and evaluable disease on MIBG scan at time of enrollment on protocol
1
[ "MIBG-avid", "NB", "and", "evaluable", "disease", "on", "MIBG", "scan", "at", "time", "of", "enrollment", "on", "protocol" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02841956
13:22:chronic_disease,
Duration of psychosis > 2 years
1
[ "Duration", "of", "psychosis", ">", "2", "years" ]
[ 0, 0, 2, 0, 0, 0 ]
NCT03110354
,,,141:177:treatment
Has prolonged corrected QT interval by Fridericia's method (QTcF) at rest, where the mean QTcF interval is > 450 milliseconds (ms) based on triplicate electrocardiograms (ECGs)
1
[ "Has", "prolonged", "corrected", "QT", "interval", "by", "Fridericia", "'s", "method", "(", "QTcF", ")", "at", "rest", ",", "where", "the", "mean", "QTcF", "interval", "is", ">", "450", "milliseconds", "(", "ms", ")", "based", "on", "triplicate", "electrocardiograms", "(", "ECGs", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0 ]
NCT03097588
48:71:treatment
Subjects who have concurrent illness requiring systemic corticosteroid use
1
[ "Subjects", "who", "have", "concurrent", "illness", "requiring", "systemic", "corticosteroid", "use" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 0 ]
NCT00911560
1:23:chronic_disease,
bone marrow metastases plus high urine catecholamine levels
1
[ "bone", "marrow", "metastases", "plus", "high", "urine", "catecholamine", "levels" ]
[ 2, 2, 2, 0, 0, 0, 0, 0 ]
NCT01903330
13:45:cancer
presence of punctate hemorrhage in the tumor
1
[ "presence", "of", "punctate", "hemorrhage", "in", "the", "tumor" ]
[ 0, 0, 3, 3, 3, 3, 3 ]
NCT02945800
12:28:chronic_disease
ongoing or active infection
1
[ "ongoing", "or", "active", "infection" ]
[ 0, 0, 2, 2 ]
NCT01954576
50:53:cancer,70:91:treatment,182:188:treatment,192:201:treatment
Unequivocal evidence of recurrent or progressive GBM before or after bevacizumab treatment first based on radiographic appearances then confirmed by histologic confirmation through biopsy or resection
1
[ "Unequivocal", "evidence", "of", "recurrent", "or", "progressive", "GBM", "before", "or", "after", "bevacizumab", "treatment", "first", "based", "on", "radiographic", "appearances", "then", "confirmed", "by", "histologic", "confirmation", "through", "biopsy", "or", "resection" ]
[ 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1 ]
NCT02245841
1:30:chronic_disease
juvenile dermatomyositis (JD)
1
[ "juvenile", "dermatomyositis", "(", "JD", ")" ]
[ 2, 2, 2, 0, 0 ]
NCT02233868
20:38:treatment
Urine positive for psychoactive drugs (clinical laboratory results) on study days involving imaging (PET and MRI) and neuropsychological testing
1
[ "Urine", "positive", "for", "psychoactive", "drugs", "(", "clinical", "laboratory", "results", ")", "on", "study", "days", "involving", "imaging", "(", "PET", "and", "MRI", ")", "and", "neuropsychological", "testing" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02337465
1:38:chronic_disease
psychiatric illness/social situations that would limit compliance with study requirements
1
[ "psychiatric", "illness/social", "situations", "that", "would", "limit", "compliance", "with", "study", "requirements" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02706288
46:60:treatment
increase the risk of study procedures (e.g., anticoagulants) and that cannot be temporarily discontinued for this study
1
[ "increase", "the", "risk", "of", "study", "procedures", "(", "e.g.", ",", "anticoagulants", ")", "and", "that", "can", "not", "be", "temporarily", "discontinued", "for", "this", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02419495
,16:29:treatment,52:61:treatment,69:76:treatment
> 4 weeks from prior therapy completion (including radiation and/or surgery)
1
[ ">", "4", "weeks", "from", "prior", "therapy", "completion", "(", "including", "radiation", "and/or", "surgery", ")" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 0, 1, 0 ]
NCT02099591
49:61:treatment
Patients currently receiving the first cycle of chemotherapy
1
[ "Patients", "currently", "receiving", "the", "first", "cycle", "of", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02501473
73:86:treatment
For patients enrolled in Part 2 or Part 4 with the potential to receive pembrolizumab
1
[ "For", "patients", "enrolled", "in", "Part", "2", "or", "Part", "4", "with", "the", "potential", "to", "receive", "pembrolizumab" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02341235
10:23:cancer,
Report a breast cancer diagnosis no more than 10 years prior to enrollmen
1
[ "Report", "a", "breast", "cancer", "diagnosis", "no", "more", "than", "10", "years", "prior", "to", "enrollmen" ]
[ 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02585973
47:74:treatment,57:74:treatment
Unable or unwilling to discontinue use of any sensitive CYP3A4 substrates and CYP3A4 substrates with a narrow therapeutic window
1
[ "Unable", "or", "unwilling", "to", "discontinue", "use", "of", "any", "sensitive", "CYP3A4", "substrates", "and", "CYP3A4", "substrates", "with", "a", "narrow", "therapeutic", "window" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02752191
38:56:treatment
other causes (for subjects receiving Feraheme injection only)
1
[ "other", "causes", "(", "for", "subjects", "receiving", "Feraheme", "injection", "only", ")" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 0, 0 ]
NCT01865162
12:40:chronic_disease
History of human immunodeficiency virus
1
[ "History", "of", "human", "immunodeficiency", "virus" ]
[ 0, 0, 2, 2, 2 ]
NCT00632853
1:13:treatment
chemotherapy
1
[ "chemotherapy" ]
[ 1 ]
NCT01366612
34:44:cancer,
Diagnosed or treated for another malignancy within 3 years of enrollment
1
[ "Diagnosed", "or", "treated", "for", "another", "malignancy", "within", "3", "years", "of", "enrollment" ]
[ 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0 ]
NCT00392756
117:129:treatment
with a single serum sample demonstrating low estradiol (estrogen) in association with low or inappropriately normal gonadotropin levels
1
[ "with", "a", "single", "serum", "sample", "demonstrating", "low", "estradiol", "(", "estrogen", ")", "in", "association", "with", "low", "or", "inappropriately", "normal", "gonadotropin", "levels" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT01849146
,16:40:treatment
6 weeks from a nitrosourea chemotherapy
1
[ "6", "weeks", "from", "a", "nitrosourea", "chemotherapy" ]
[ 0, 0, 0, 0, 1, 1 ]
NCT02200445
25:46:chronic_disease
Positive stool test for Clostridium difficile
1
[ "Positive", "stool", "test", "for", "Clostridium", "difficile" ]
[ 0, 0, 0, 0, 2, 2 ]
NCT01415752
36:62:cancer,93:119:treatment,155:196:treatment
Histologically confirmed untreated mantle cell lymphoma (MCL), with documented cyclin D1 by immunohistochemical stains and/or t(11;14) by cytogenetics or fluorescence in situ hybridization (FISH)
1
[ "Histologically", "confirmed", "untreated", "mantle", "cell", "lymphoma", "(", "MCL", ")", ",", "with", "documented", "cyclin", "D1", "by", "immunohistochemical", "stains", "and/or", "t", "(", "11", ";", "14", ")", "by", "cytogenetics", "or", "fluorescence", "in", "situ", "hybridization", "(", "FISH", ")" ]
[ 0, 0, 0, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0 ]
NCT00887146
35:42:cancer
Patients with codeleted low grade gliomas must also be considered high risk by exhibiting one or more of the following characteristics
1
[ "Patients", "with", "codeleted", "low", "grade", "gliomas", "must", "also", "be", "considered", "high", "risk", "by", "exhibiting", "one", "or", "more", "of", "the", "following", "characteristics" ]
[ 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02386605
1:22:chronic_disease
Neurological disorder
1
[ "Neurological", "disorder" ]
[ 2, 2 ]
NCT03151330
,50:68:chronic_disease
The subject has known elevated bilirubin levels (hyperbilirubinemia)
1
[ "The", "subject", "has", "known", "elevated", "bilirubin", "levels", "(", "hyperbilirubinemia", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 2, 0 ]
NCT03068442
7:20:cancer,31:49:chronic_disease,53:64:cancer
Known stroke mimics including multiple sclerosis or brain tumor
1
[ "Known", "stroke", "mimics", "including", "multiple", "sclerosis", "or", "brain", "tumor" ]
[ 0, 3, 3, 0, 2, 2, 0, 3, 3 ]
NCT03096418
,40:53:cancer
Women with pathologically demonstrated breast cancer
1
[ "Women", "with", "pathologically", "demonstrated", "breast", "cancer" ]
[ 0, 0, 0, 0, 3, 3 ]
NCT01928576
31:49:chronic_disease
Any active history of a known autoimmune disease
1
[ "Any", "active", "history", "of", "a", "known", "autoimmune", "disease" ]
[ 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02551679
9:33:treatment
Chronic cytotoxic drug treatment
1
[ "Chronic", "cytotoxic", "drug", "treatment" ]
[ 0, 1, 1, 1 ]
NCT02964039
14:22:chronic_disease
Uncontrolled diabetes with recent weight loss, diabetic coma, or frequent insulin reactions
1
[ "Uncontrolled", "diabetes", "with", "recent", "weight", "loss", ",", "diabetic", "coma", ",", "or", "frequent", "insulin", "reactions" ]
[ 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02495753
,19:49:chronic_disease
women with active herpes simplex virus infection
1
[ "women", "with", "active", "herpes", "simplex", "virus", "infection" ]
[ 0, 0, 0, 2, 2, 2, 2 ]
NCT02438995
,25:48:treatment
Less than 6 months from prior Radiation Therapy (Arm 1)
1
[ "Less", "than", "6", "months", "from", "prior", "Radiation", "Therapy", "(", "Arm", "1", ")" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0 ]
NCT02250157
28:55:treatment
Require therapeutic use of anticoagulation medications
1
[ "Require", "therapeutic", "use", "of", "anticoagulation", "medications" ]
[ 0, 0, 0, 0, 1, 1 ]
NCT02423863
26:40:treatment
Persistent toxicity from recent therapy that has not sufficiently resolved in the judgment of the study physician
1
[ "Persistent", "toxicity", "from", "recent", "therapy", "that", "has", "not", "sufficiently", "resolved", "in", "the", "judgment", "of", "the", "study", "physician" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02423863
,,,,128:143:treatment
Transaminases ≤ 2 times above the upper limits of the institutional normal, - INR<2 (international normalized ratio) if off of anticoagulation
1
[ "Transaminases", "≤", "2", "times", "above", "the", "upper", "limits", "of", "the", "institutional", "normal", ",", "-", "INR", "<", "2", "(", "international", "normalized", "ratio", ")", "if", "off", "of", "anticoagulation" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02583893
1:11:treatment,18:25:treatment,43:54:treatment,56:68:treatment,70:82:treatment,84:96:treatment,102:114:treatment,
Tacrolimus (e.g. Prograf) Subjects taking fluconozole, voriconizole, itraconazole, posaconazole, and ketokonazole within 72 hours of study drug starting
1
[ "Tacrolimus", "(", "e.g", ".", "Prograf", ")", "Subjects", "taking", "fluconozole", ",", "voriconizole", ",", "itraconazole", ",", "posaconazole", ",", "and", "ketokonazole", "within", "72", "hours", "of", "study", "drug", "starting" ]
[ 1, 0, 0, 0, 1, 0, 0, 0, 1, 0, 1, 0, 1, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02072148
21:59:treatment,
Participation in an investigational therapeutic drug trial within 30 days of study entry
1
[ "Participation", "in", "an", "investigational", "therapeutic", "drug", "trial", "within", "30", "days", "of", "study", "entry" ]
[ 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT01591356
34:55:chronic_disease,106:123:chronic_disease,125:137:chronic_disease,142:147:cancer
Patients with active bleeding or pathologic conditions that carry high risk of bleeding, such as a known bleeding disorder, coagulopathy, or tumor involving major vessels
1
[ "Patients", "with", "active", "bleeding", "or", "pathologic", "conditions", "that", "carry", "high", "risk", "of", "bleeding", ",", "such", "as", "a", "known", "bleeding", "disorder", ",", "coagulopathy", ",", "or", "tumor", "involving", "major", "vessels" ]
[ 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 3, 0, 0, 0 ]
NCT00719888
,,97:109:treatment
ligible with (M2 marrow) with =< 25% blasts in marrow after having failed one or more cycles of chemotherapy
1
[ "ligible", "with", "(", "M2", "marrow", ")", "with", "=", "<", "25", "%", "blasts", "in", "marrow", "after", "having", "failed", "one", "or", "more", "cycles", "of", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT01543490
10:24:treatment,
Have had eyelid surgery in the study eye within twelve (12) months prior to Visit 1 or plan to have eyelid surgery during the study
1
[ "Have", "had", "eyelid", "surgery", "in", "the", "study", "eye", "within", "twelve", "(", "12", ")", "months", "prior", "to", "Visit", "1", "or", "plan", "to", "have", "eyelid", "surgery", "during", "the", "study" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02127398
1:12:treatment
gastrostomy
1
[ "gastrostomy" ]
[ 1 ]
NCT02918175
1:22:chronic_disease,9:22:chronic_disease,,,,84:93:treatment,99:110:treatment,
Chronic heart failure, New York Heart Association (NYHA) class II-IV, with ongoing treatment with medications for heart failure for at least 1 month prior to enrollment
1
[ "Chronic", "heart", "failure", ",", "New", "York", "Heart", "Association", "(", "NYHA", ")", "class", "II-IV", ",", "with", "ongoing", "treatment", "with", "medications", "for", "heart", "failure", "for", "at", "least", "1", "month", "prior", "to", "enrollment" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02808442
1:45:cancer
Active Central Nervous System (CNS) leukemia
1
[ "Active", "Central", "Nervous", "System", "(", "CNS", ")", "leukemia" ]
[ 3, 3, 3, 3, 3, 3, 0, 0 ]
NCT02231073
1:13:chronic_disease,24:56:chronic_disease,65:95:chronic_disease,97:120:chronic_disease,122:143:chronic_disease,148:165:chronic_disease
Parkinsonism subjects: iPD and Parkinson plus syndromes such as Progressive Supranuclear Palsy, Multiple System Atrophy, Corticobasal Syndrome, or Cerebellar Ataxia
1
[ "Parkinsonism", "subjects", ":", "iPD", "and", "Parkinson", "plus", "syndromes", "such", "as", "Progressive", "Supranuclear", "Palsy", ",", "Multiple", "System", "Atrophy", ",", "Corticobasal", "Syndrome", ",", "or", "Cerebellar", "Ataxia" ]
[ 2, 0, 0, 2, 2, 2, 2, 2, 0, 0, 2, 2, 2, 0, 2, 2, 2, 0, 2, 2, 0, 0, 2, 2 ]
NCT02466126
30:43:treatment
Veterans currently receiving psychotherapy WILL be excluded
1
[ "Veterans", "currently", "receiving", "psychotherapy", "WILL", "be", "excluded" ]
[ 0, 0, 0, 1, 0, 0, 0 ]
NCT02099058
26:45:treatment
Subjects enrolled on the combination therapy phase must satisfy the above exclusion criteria
1
[ "Subjects", "enrolled", "on", "the", "combination", "therapy", "phase", "must", "satisfy", "the", "above", "exclusion", "criteria" ]
[ 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT03107520
7:35:chronic_disease
Known heart or pulmonary condition
1
[ "Known", "heart", "or", "pulmonary", "condition" ]
[ 0, 2, 2, 2, 2 ]
NCT02857218
12:28:chronic_disease
ongoing or active infection
1
[ "ongoing", "or", "active", "infection" ]
[ 0, 0, 2, 2 ]
NCT02130687
1:44:treatment,
Treatment with antihypertensive medications for a minimum of 6 months
1
[ "Treatment", "with", "antihypertensive", "medications", "for", "a", "minimum", "of", "6", "months" ]
[ 1, 1, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT03038620
1:8:treatment
Surgery scheduled for the trial duration period
1
[ "Surgery", "scheduled", "for", "the", "trial", "duration", "period" ]
[ 1, 0, 0, 0, 0, 0, 0 ]
NCT01445821
1:4:chronic_disease
HIV positive
1
[ "HIV", "positive" ]
[ 2, 0 ]
NCT03112603
52:64:chronic_disease
Participants with clinically diagnosed moderate to severe cGvHD according to NIH Consensus Criteria prior to randomization
1
[ "Participants", "with", "clinically", "diagnosed", "moderate", "to", "severe", "cGvHD", "according", "to", "NIH", "Consensus", "Criteria", "prior", "to", "randomization" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02869789
27:45:chronic_disease
ctive, known or suspected autoimmune disease
1
[ "ctive", ",", "known", "or", "suspected", "autoimmune", "disease" ]
[ 0, 0, 0, 0, 0, 2, 2 ]
NCT03073629
12:37:chronic_disease,41:55:chronic_disease,73:89:treatment
those with indeterminate RV function OR LV dysfunction on comprehensive echocardiography
1
[ "those", "with", "indeterminate", "RV", "function", "OR", "LV", "dysfunction", "on", "comprehensive", "echocardiography" ]
[ 0, 0, 2, 2, 2, 0, 2, 2, 0, 0, 1 ]
NCT01059786
35:46:treatment,47:54:treatment,,112:127:treatment
The patient may have any required vaccination/booster administered at least 4 weeks prior to the initiation of study treatment
1
[ "The", "patient", "may", "have", "any", "required", "vaccination/booster", "administered", "at", "least", "4", "weeks", "prior", "to", "the", "initiation", "of", "study", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02013154
1:10:treatment,16:31:treatment,,84:108:treatment,
Treatment with corticosteroids (≥ 10 mg per day prednisone or equivalent) or other immune suppressive drugs within the 14 days prior to study entry
1
[ "Treatment", "with", "corticosteroids", "(", "≥", "10", "mg", "per", "day", "prednisone", "or", "equivalent", ")", "or", "other", "immune", "suppressive", "drugs", "within", "the", "14", "days", "prior", "to", "study", "entry" ]
[ 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03101956
1:35:chronic_disease
Nervous system disease or disorder
1
[ "Nervous", "system", "disease", "or", "disorder" ]
[ 2, 2, 2, 2, 2 ]
NCT03171493
,,98:107:treatment
Men or women of childbearing potential who are unwilling to employ adequate contraception during treatment and 8 weeks following the completion of study drug treatment
1
[ "Men", "or", "women", "of", "childbearing", "potential", "who", "are", "unwilling", "to", "employ", "adequate", "contraception", "during", "treatment", "and", "8", "weeks", "following", "the", "completion", "of", "study", "drug", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01494662
4:32:treatment
No prior therapy with neratinib
1
[ "No", "prior", "therapy", "with", "neratinib" ]
[ 0, 1, 1, 1, 1 ]
NCT02232516
,,69:71:treatment
Patients must have bi-dimensionally measurable disease (>= 1 cm) by CT imaging
1
[ "Patients", "must", "have", "bi-dimensionally", "measurable", "disease", "(", ">", "=", "1", "cm", ")", "by", "CT", "imaging" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT02488057
1:9:chronic_disease
diabetic
1
[ "diabetic" ]
[ 2 ]
NCT02013154
7:35:cancer
Known osteoblastic bony metastasis
1
[ "Known", "osteoblastic", "bony", "metastasis" ]
[ 0, 3, 3, 3 ]
NCT01943851
23:45:chronic_disease
Evidence of severe of uncontrolled infection
1
[ "Evidence", "of", "severe", "of", "uncontrolled", "infection" ]
[ 0, 0, 0, 0, 2, 2 ]
NCT01988246
1:70:treatment,
Intravitreal anti-VEGF (vascular endothelial growth factor) treatment in the study eye within 6 months of the pre-operative baseline visit
1
[ "Intravitreal", "anti-VEGF", "(", "vascular", "endothelial", "growth", "factor", ")", "treatment", "in", "the", "study", "eye", "within", "6", "months", "of", "the", "pre-operative", "baseline", "visit" ]
[ 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03131037
23:47:chronic_disease,57:72:chronic_disease,74:98:chronic_disease,112:156:chronic_disease
Presence of any other life-threatening illness, such as unstable angina, severe oxygen dependence, significant chronic obstructive pulmonary disease (COPD)
1
[ "Presence", "of", "any", "other", "life-threatening", "illness", ",", "such", "as", "unstable", "angina", ",", "severe", "oxygen", "dependence", ",", "significant", "chronic", "obstructive", "pulmonary", "disease", "(", "COPD", ")" ]
[ 0, 0, 0, 0, 2, 2, 0, 0, 0, 2, 2, 0, 2, 2, 2, 0, 0, 2, 2, 2, 2, 2, 0, 0 ]
NCT02852057
1:12:chronic_disease
Bradycardia
1
[ "Bradycardia" ]
[ 2 ]
NCT02301611
12:32:treatment,64:76:treatment,78:95:treatment
Completing SoC adjuvant therapy per NCCN guidelines to include chemotherapy, radiation therapy
1
[ "Completing", "SoC", "adjuvant", "therapy", "per", "NCCN", "guidelines", "to", "include", "chemotherapy", ",", "radiation", "therapy" ]
[ 0, 1, 1, 1, 0, 0, 0, 0, 0, 1, 0, 1, 1 ]
NCT02907944
108:117:treatment
Meets criteria for lifetime or current tobacco, alcohol and/or opioid use disorder regardless of addiction treatment status
1
[ "Meets", "criteria", "for", "lifetime", "or", "current", "tobacco", ",", "alcohol", "and/or", "opioid", "use", "disorder", "regardless", "of", "addiction", "treatment", "status" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT01532687
3:15:treatment
A hysterectomy
1
[ "A", "hysterectomy" ]
[ 0, 1 ]
NCT03082612
46:58:treatment
Treatment plans to include weekly outpatient chemotherapy
1
[ "Treatment", "plans", "to", "include", "weekly", "outpatient", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 1 ]
NCT02091999
18:37:chronic_disease,39:44:cancer,49:52:treatment
Dose Escalation, Renal insufficiency, NSCLC and CPI-Treated Expansion Cohorts
1
[ "Dose", "Escalation", ",", "Renal", "insufficiency", ",", "NSCLC", "and", "CPI-Treated", "Expansion", "Cohorts" ]
[ 0, 0, 0, 2, 2, 0, 3, 0, 1, 0, 0 ]
NCT02352480
22:30:treatment,
Subject has received UCC care for ≥ 2 weeks at treating wound clinic
1
[ "Subject", "has", "received", "UCC", "care", "for", "≥", "2", "weeks", "at", "treating", "wound", "clinic" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01791543
10:46:chronic_disease,50:79:treatment,85:96:treatment
Definite protruding left ventricular thrombus on pre-ablation echocardiography when LV ablation is required
1
[ "Definite", "protruding", "left", "ventricular", "thrombus", "on", "pre-ablation", "echocardiography", "when", "LV", "ablation", "is", "required" ]
[ 0, 2, 2, 2, 2, 0, 1, 1, 0, 1, 1, 0, 0 ]
NCT02091141
1:19:treatment,25:36:treatment,50:64:treatment,66:81:treatment
Previous treatment with vemurafenib or any other BRAF inhibitor (prior sorafenib is allowed)
1
[ "Previous", "treatment", "with", "vemurafenib", "or", "any", "other", "BRAF", "inhibitor", "(", "prior", "sorafenib", "is", "allowed", ")" ]
[ 1, 1, 0, 1, 0, 0, 0, 1, 1, 0, 1, 1, 0, 0, 0 ]
NCT02347995
38:46:chronic_disease,,,,
untreated and / or poorly controlled diabetes with fasting blood glucose of greater than 170 and HbA1c greater than 10.0
1
[ "untreated", "and", "/", "or", "poorly", "controlled", "diabetes", "with", "fasting", "blood", "glucose", "of", "greater", "than", "170", "and", "HbA1c", "greater", "than", "10.0" ]
[ 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02690116
14:21:chronic_disease,,
Experiencing fatigue (scoring < 75 on Vitality scale of Short Form (SF)-36)
1
[ "Experiencing", "fatigue", "(", "scoring", "<", "75", "on", "Vitality", "scale", "of", "Short", "Form", "(", "SF", ")", "-36", ")" ]
[ 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02946892
1:18:chronic_disease,,
Renal dysfunction defined as serum creatinine >2.0mg/dL
1
[ "Renal", "dysfunction", "defined", "as", "serum", "creatinine", ">", "2.0mg/dL" ]
[ 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02562430
53:61:allergy_name
History of inadequate response/poor tolerability to bupropio
1
[ "History", "of", "inadequate", "response/poor", "tolerability", "to", "bupropio" ]
[ 0, 0, 0, 0, 0, 0, 4 ]
NCT01421810
23:31:chronic_disease,,,,
Previous diagnosis of diabetes, fasting glucose ≥126 mg/dL, or a hemoglobin A1c >6.5%
1
[ "Previous", "diagnosis", "of", "diabetes", ",", "fasting", "glucose", "≥126", "mg/dL", ",", "or", "a", "hemoglobin", "A1c", ">", "6.5", "%" ]
[ 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02369406
1:4:chronic_disease,,
HIV-positive between 96 hours and 42 days after birth
1
[ "HIV-positive", "between", "96", "hours", "and", "42", "days", "after", "birth" ]
[ 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01943851
67:77:treatment
This method must be used from the time of the first dose of study medication until 16 weeks after the last dose of study medication
1
[ "This", "method", "must", "be", "used", "from", "the", "time", "of", "the", "first", "dose", "of", "study", "medication", "until", "16", "weeks", "after", "the", "last", "dose", "of", "study", "medication" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02101853
1:18:treatment,11:18:treatment,,61:78:treatment,101:112:chronic_disease,,191:215:treatment,220:244:treatment,246:258:treatment
Cytotoxic therapy: at least 14 days since the completion of cytotoxic therapy with the exception of hydroxyurea, which is permitted up to 24 hours prior to the start of protocol therapy, or maintenance chemotherapy, or intrathecal chemotherapy (methotrexate strongly preferred) administered at the time of the required diagnostic lumbar puncture to establish baseline CNS status
1
[ "Cytotoxic", "therapy", ":", "at", "least", "14", "days", "since", "the", "completion", "of", "cytotoxic", "therapy", "with", "the", "exception", "of", "hydroxyurea", ",", "which", "is", "permitted", "up", "to", "24", "hours", "prior", "to", "the", "start", "of", "protocol", "therapy", ",", "or", "maintenance", "chemotherapy", ",", "or", "intrathecal", "chemotherapy", "(", "methotrexate", "strongly", "preferred", ")", "administered", "at", "the", "time", "of", "the", "required", "diagnostic", "lumbar", "puncture", "to", "establish", "baseline", "CNS", "status" ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02271100
13:22:chronic_disease
Significant scoliosis
1
[ "Significant", "scoliosis" ]
[ 0, 2 ]
NCT02784535
60:82:treatment,84:105:treatment,107:128:treatment,130:154:treatment,156:177:treatment
Use of other norepinephrine transporter inhibitors such as Wellbutrin (Bupropion), Cymbalta (Duloxetine), Effexor (venlafaxine), Pristiq (desvenlafaxine), Savella (milnacipran)
1
[ "Use", "of", "other", "norepinephrine", "transporter", "inhibitors", "such", "as", "Wellbutrin", "(", "Bupropion", ")", ",", "Cymbalta", "(", "Duloxetine", ")", ",", "Effexor", "(", "venlafaxine", ")", ",", "Pristiq", "(", "desvenlafaxine", ")", ",", "Savella", "(", "milnacipran", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0 ]
NCT02932410
6:38:chronic_disease
with pulmonary veno-occlusive disease
1
[ "with", "pulmonary", "veno-occlusive", "disease" ]
[ 0, 2, 2, 2 ]
NCT01433315
54:86:chronic_disease
The investigators will exclude subjects who have any medical or psychiatric disorders
1
[ "The", "investigators", "will", "exclude", "subjects", "who", "have", "any", "medical", "or", "psychiatric", "disorders" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2 ]
NCT02046330
35:44:treatment
Presence of a condition requiring diathermy
1
[ "Presence", "of", "a", "condition", "requiring", "diathermy" ]
[ 0, 0, 0, 0, 0, 1 ]
NCT01614197
29:50:treatment,,
Patients must have been off blinatumomab infusion for at least 4 days and all drug-related toxicity must have resolved to grade 2 or lower as outlined in the inclusion and exclusion criteria
1
[ "Patients", "must", "have", "been", "off", "blinatumomab", "infusion", "for", "at", "least", "4", "days", "and", "all", "drug-related", "toxicity", "must", "have", "resolved", "to", "grade", "2", "or", "lower", "as", "outlined", "in", "the", "inclusion", "and", "exclusion", "criteria" ]
[ 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02750319
13:25:chronic_disease
Patients in sinus rhythm
1
[ "Patients", "in", "sinus", "rhythm" ]
[ 0, 0, 2, 2 ]
NCT02414269
1:45:treatment,52:65:treatment,67:81:treatment,85:100:treatment,,175:190:treatment
Prior immunotherapy with checkpoint blockade (i.e. PD1 inhibitor, PDL1 inhibitor or CTL4-antagonist or similar agent) must have been completed more than 1 month1prior to the T cell infusion
1
[ "Prior", "immunotherapy", "with", "checkpoint", "blockade", "(", "i.e", ".", "PD1", "inhibitor", ",", "PDL1", "inhibitor", "or", "CTL4-antagonist", "or", "similar", "agent", ")", "must", "have", "been", "completed", "more", "than", "1", "month1prior", "to", "the", "T", "cell", "infusion" ]
[ 1, 1, 1, 1, 1, 0, 0, 0, 1, 1, 0, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT02419495
1:13:treatment,18:31:treatment,45:72:treatment,,93:103:treatment,144:163:treatment,154:163:treatment,226:235:treatment,290:311:treatment,335:359:treatment
Chemotherapy, or immunotherapy or any other systemic anticancer therapy =< 3 weeks prior to study drug administration date; patients receiving anti-PD-1 treatment, and continue to receiving this treatment in combination with selinexor (Arms L and M), can start receiving the selinexor and anti-PD-1 combination without washout of the prior anti-PD-1 antibody
1
[ "Chemotherapy", ",", "or", "immunotherapy", "or", "any", "other", "systemic", "anticancer", "therapy", "=", "<", "3", "weeks", "prior", "to", "study", "drug", "administration", "date", ";", "patients", "receiving", "anti-PD-1", "treatment", ",", "and", "continue", "to", "receiving", "this", "treatment", "in", "combination", "with", "selinexor", "(", "Arms", "L", "and", "M", ")", ",", "can", "start", "receiving", "the", "selinexor", "and", "anti-PD-1", "combination", "without", "washout", "of", "the", "prior", "anti-PD-1", "antibody" ]
[ 1, 0, 0, 1, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]